vimarsana.com
Home
Live Updates
AB-1002 Demonstrates Improvements for Congestive Heart Failure in First-in-Human Study : vimarsana.com
AB-1002 Demonstrates Improvements for Congestive Heart Failure in First-in-Human Study : vimarsana.com
AB-1002 Demonstrates Improvements for Congestive Heart Failure in First-in-Human Study
Improvements were seen in left ventricular ejection fraction, NYHA Functional Class, and Minnesota Living with Heart Failure Questionnaire at 1-year post-dose.
Related Keywords
United States ,
Minnesota ,
Pennsylvania ,
Philadelphia ,
American ,
Litsag Kranias ,
Dragana Gordic ,
Timothyd Henry ,
National Library Of Medicine ,
Steering Committee ,
University Of Cincinnati ,
American Heart Association Scientific Session ,
Asklepios Biopharmaceuticals Inc ,
Hanna Chair ,
National Library ,
Minnesota Living ,
Heart Failure Questionnaire ,